PBP1502

adalimumab biosimilar · Prestige Biopharma Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBP1502, covering 2025-05-31 to 2025-05-31. Get the full timeline:

Most recent: Clinical Trial Update: To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects [Phase 1]